Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9581304 | 0.98 | ACHE (0.33) | TDP1L3MBTL1ACHEBACE1 | |
| Hydrochloric Acid SCHEMBL4339155 | 0.98 | ACHE (0.33) | TDP1L3MBTL1ACHEBACE1 | |
| Fluoride Ion SCHEMBL5085381 | 0.96 | TDP1 (0.30) | TDP1L3MBTL1ACHEBACE1 | |
| Hydrochloric Acid SCHEMBL45368 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL5486364 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL2277860 | 0.91 | — | — | |
| SCHEMBL4576636 | 0.91 | — | — | |
| Fluoride Ion SCHEMBL1130342 | 0.91 | — | — | |
| Bromide SCHEMBL28815501 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL618009 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11193008-B2 | Methods for making polyolefin polymer compositions | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-07 | — | — | US | claimed |
| US-20200056026-A1 | Methods for Making Polyolefin Polymer Compositions | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2020-02-20 | — | — | US | claimed |
| WO-2018191000-A1 | METHODS FOR MAKING POLYOLEFIN POLYMER COMPOSITIONS | EXXONMOBIL CHEMICL PATENTS INC. (US) | 2018-10-18 | — | — | WO | claimed |
| US-RE40751-E1 | Polymerization catalyst systems comprising substituted hafnocenes | UNIVATION TECHNOLOGIES, LLC (US) | 2009-06-16 | — | — | US | claimed |
| EP-1037930-B1 | POLYMERIZATION CATALYST SYSTEMS, THEIR USE, THEIR PRODUCTS AND ARTICLES THEREOF | UNIVATION TECH LLC (US) | 2006-02-22 | — | — | EP | claimed |
| US-12528892-B2 | Alkylation of transition metal coordination catalyst complexes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20250353944-A1 | POLYETHYLENE COMPOSITIONS AND RELATED BICOMPONENT FIBERS, NONWOVEN FABRICS, AND METHODS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4536718-A1 | POLYETHYLENE COMPOSITIONS AND RELATED BICOMPONENT FIBERS, NONWOVEN FABRICS, AND METHODS | ExxonMobil Chemical Patents Inc. (US) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023244899-A1 | POLYETHYLENE COMPOSITIONS AND RELATED BICOMPONENT FIBERS, NONWOVEN FABRICS, AND METHODS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| US-20230141606-A1 | Alkylation of Transition Metal Coordination Catalyst Complexes | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-05-11 | — | — | US | disclosed |
| US-11629245-B2 | Polyethylene compositions, wire and cables, and methods for making the same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-04-18 | — | — | US | disclosed |
| US-11193008-B2 | Methods for making polyolefin polymer compositions | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-07 | — | — | US | disclosed |
| US-20010020074-A1 | Polymerization catalyst systems and their use | EXXON CHEMICAL PATENTS, INC. | 2001-09-06 | — | — | US | disclosed |
| US-20010018505-A1 | Polymerization catalyst systems and their use | UNIVATION TECHNOLOGIES, LLC | 2001-08-30 | — | — | US | disclosed |
| US-6248845-B1 | Polymerization catalyst systems comprising substituted hafnocenes | UNIVATION TECHNOLOGIES | 2001-06-19 | — | — | US | disclosed |
| US-6242545-B1 | POLYMERIZING OLEFIN(S) IN THE PRESENCE OF A HAFNIUM METALLOCENE CATALYST COMPOUND HAVING A CYCLOPENTADIENYL LIGAND OR DERIVATIVE WITH AT LEAST ONE LINEAR OR ISO ALKYL GROUP ACTIVATOR | UNIVATION TECHNOLOGIES | 2001-06-05 | — | — | US | disclosed |
| EP-1071690-A1 | METALLOCENE PURIFICATION PROCESS | ALBEMARLE CORPORATION (US) | 2001-01-31 | — | — | EP | disclosed |
| EP-1037930-A1 | POLYMERIZATION CATALYST SYSTEMS, THEIR USE, THEIR PRODUCTS AND ARTICLES THEREOF | Univation Technologies LLC (US) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999052919-A1 | METALLOCENE PURIFICATION PROCESS | ALBEMARLE CORPORATION (US) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999029737-A1 | POLYMERIZATION CATALYST SYSTEMS, THEIR USE, THEIR PRODUCTS AND ARTICLES THEREOF | UNIVATION TECHNOLOGIES LLC (US) | 1999-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528892-B2 | Alkylation of transition metal coordination catalyst complexes | LEF1, TAF1, FLI1 | ACHE 2481/4885TDP1 2040/4885L3MBTL1 2996/4885 |
| US-20230141606-A1 | Alkylation of Transition Metal Coordination Catalyst Complexes | AS3MT, AP1M1, AP3M1 | ACHE 2559/4885TDP1 3031/4885L3MBTL1 2618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.